Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rovere, F. D."'
Autor:
Ribichini F., Ansalone G., Bartorelli A., Beqaraj F., Berni A., Colangelo S., D'Amico M., Rovere F. D., Fiscella A., Gabrielli G., Indolfi C., La Vecchia L., Loschiavo P., Marinoni G., Marzocchi A., Milazzo D., Romano M., Sangiorgio P., Sheiban I., Tamburino C., Tuccillo B., Villani R., Cappi B., Quijada M. J. L., Vassanelli C., investigators group, C. Spaccarotella
Publikováno v:
Journal of cardiovascular medicine (Hagerstown, Md.). 11(4)
Background: Myocardial revascularization with drug-eluting stents (DESs) is emerging as an alternative to conventional coronary artery bypass surgery in patients with multivessel coronary artery disease (MV-CAD). First-generation DESs have yielded eq
Autor:
Ribichini, Flavio Luciano, Romano, M., Rosiello, R., Vecchia, L. L., Cabianca, E., Caramanno, G., Milazzo, D., Loschiavo, P., Rigattieri, S., Musarò, S., Pironi, B., Fiscella, A., Amico, F., Indolfi, C., Spaccarotella, C., Bartorelli, A., Trabattoni, D., Rovere, F. D., Rolandi, A., Beqaraj, F., Belli, R., Sangiorgio, P., Villani, R., Berni, A., Sheiban, I., Lopera, M. J., Cappi, B., Ribaldi, L., Vassanelli, Corrado, E. X. E.
This study sought to investigate the efficacy and performance of the XIENCE V everolimus-eluting stent (EES) (Abbott Vascular, Santa Clara, California) in the treatment of de novo coronary lesions in patients with 2- to 3-vessel multivessel coronary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2a4ccce9e2847158e3c1addc1963cfa1
http://hdl.handle.net/11573/559284
http://hdl.handle.net/11573/559284
Publikováno v:
Minerva medica [Minerva Med] 1979 Sep 15; Vol. 70 (38), pp. 2621-8.